Literature DB >> 12121612

Translation is required to remove Y14 from mRNAs in the cytoplasm.

Josée Dostie1, Gideon Dreyfuss.   

Abstract

BACKGROUND: Y14 is an RNA binding protein which is part of a multiprotein complex, the exon-exon junction complex (EJC), that assembles on the exon-exon junctions of mRNAs produced by splicing. The position-specific binding of Y14 persists on mRNAs after their export to the cytoplasm. Thus, Y14, together with its interacting proteins, has the capacity to communicate to the cytoplasm the processing history of the mRNA, including the position of the removed introns, information that is likely to be important for defining premature termination codons. How Y14 and other components of the EJC are removed from mRNAs into the cytoplasm has not been determined.
RESULTS: We show that Y14 but not another EJC component, Aly/REF, is present in polysome profile fractions containing one ribosome per mRNA. Using reporter constructs in an in vitro splicing/translation-coupled system, we show that Y14 remains associated with untranslated mRNAs but is removed from translationally active mRNAs. Importantly, mRNAs whose translation in vivo is prevented by the presence of strong secondary 5' UTR structure retain Y14 in the cytoplasm.
CONCLUSIONS: These findings indicate that Y14 remains associated with mRNAs in the cytoplasm until they are translated, and translation is required to remove Y14 from mRNAs. Thus, the process of translation removes the splicing-dependent EJC protein imprints, which most likely function in the surveillance of mRNAs to define premature termination codons and possibly also in modulating the translation activity of cytoplasmic mRNAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121612     DOI: 10.1016/s0960-9822(02)00902-8

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  100 in total

1.  Crystal structure of the Drosophila Mago nashi-Y14 complex.

Authors:  Hang Shi; Rui-Ming Xu
Journal:  Genes Dev       Date:  2003-04-15       Impact factor: 11.361

2.  5' exon interactions within the human spliceosome establish a framework for exon junction complex structure and assembly.

Authors:  Vienna L Reichert; Hervé Le Hir; Melissa S Jurica; Melissa J Moore
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

3.  RNA-binding ability of PIPPin requires the entire protein.

Authors:  Lavinia Raimondi; Matilde D'Asaro; Patrizia Proia; Tommaso Nastasi; Italia Di Liegro
Journal:  J Cell Mol Med       Date:  2003 Jan-Mar       Impact factor: 5.310

4.  Splicing enhances translation in mammalian cells: an additional function of the exon junction complex.

Authors:  Ajit Nott; Hervé Le Hir; Melissa J Moore
Journal:  Genes Dev       Date:  2004-01-15       Impact factor: 11.361

5.  eIF4A3 is a novel component of the exon junction complex.

Authors:  Chia C Chan; Josee Dostie; Michael D Diem; Wenqin Feng; Matthias Mann; Juri Rappsilber; Gideon Dreyfuss
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

Review 6.  Nuclear translation: what is the evidence?

Authors:  James E Dahlberg; Elsebet Lund; Elizabeth B Goodwin
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

7.  The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation.

Authors:  Marie-Joëlle Schmidt; Steven West; Chris J Norbury
Journal:  RNA       Date:  2010-11-04       Impact factor: 4.942

Review 8.  The exon junction complex as a node of post-transcriptional networks.

Authors:  Hervé Le Hir; Jérôme Saulière; Zhen Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-16       Impact factor: 94.444

9.  Nuclear Pnn/DRS protein binds to spliced mRNPs and participates in mRNA processing and export via interaction with RNPS1.

Authors:  Chin Li; Ru-Inn Lin; Ming-Chih Lai; Pin Ouyang; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Posttranscriptional control of the stem cell and neurogenic programs by the nonsense-mediated RNA decay pathway.

Authors:  Chih H Lou; Ada Shao; Eleen Y Shum; Josh L Espinoza; Lulu Huang; Rachid Karam; Miles F Wilkinson
Journal:  Cell Rep       Date:  2014-02-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.